EUVIMEDEUVIMED entdecken
Crossref

Superior antiglycation efficacy of silymarin from Silybum marianum in human αA-crystallin: Implications for diabetic cataract prevention

Yen-Ju Yang, Yi-Ping Yu, Kuan-Hung Lin, Chun-Ping Lu

Bioscience, Biotechnology, and Biochemistry · 2026

DOI: 10.1093/bbb/zbag005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2026. Verfasst von Yen-Ju Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science, Fu Jen Catholic University, New Taipei City 242062, Taiwan. Hauptthemen laut MEDLINE: Cataract, Silymarin, alpha-Crystallin A Chain, Diabetes Complications. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Science and Technology Council, Fu Jen Catholic University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperglycemia activates the polyol pathway, producing fructose, which promotes glycation and denatures α-crystallin, ultimately leading to diabetic cataracts. This study compared the antiglycation effects of SMR and SBN, using a fructose-induced human αA-crystallin glycation model. Through fluorescence analysis, SDS-PAGE, and Western blotting methods, we found that glycation caused αA-crystallin to form fluorescent advanced glycation end products (AGEs), cross-linking AGEs, and Nε-carboxymethyllysine (CML). Results show that SMR (> 20 μg/mL) and SBN (> 100 μg/mL) effectively inhibited cross-linking AGEs and CML formation. At concentrations above 4 μg/mL, both significantly reduced fluorescent AGEs, with SMR showing 91.0 ± 0.8% inhibition and SBN 81.1 ± 1.7% at 100 μg/mL. SMR also outperformed aminoguanidine hydrochloride in reducing carbonyl content at 500 μg/mL. Therefore, SMR exhibited stronger antiglycation and antioxidation properties than SBN, showing potential as a natural health product to prevent diabetic cataract formation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CataractSilymarinalpha-Crystallin A ChainDiabetes ComplicationsHumansAntiglycation AgentsGlycation End Products, AdvancedGlycosylationLysineFructoseGuanidines

Stichwörter der Autor:innen

AGEsGlycationSilibininSilymarinαA-Crystallin

Substanzen

Antiglycation AgentsGlycation End Products, AdvancedSilymarinLysineN(6)-carboxymethyllysinealpha-Crystallin A ChainpimagedineFructoseGuanidines

Autor:innen und Institutionen

  • Department of Food Science, Fu Jen Catholic University, New Taipei City 242062, Taiwan.
  • Department of Nutrition and Health Sciences, Chinese Culture University, Taipei 11114, Taiwan.
  • Department of Horticulture and Biotechnology, Chinese Culture University, Taipei 11114, Taiwan.

Förderung

  • National Science and Technology Council
  • Fu Jen Catholic University

Zitieren

APA

Yang, Y. J., Yu, Y. P., Lin, K. H., & Lu, C. P. (2026). Superior antiglycation efficacy of silymarin from Silybum marianum in human αA-crystallin: Implications for diabetic cataract prevention. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbag005

Vancouver

Yang YJ, Yu YP, Lin KH, Lu CP. Superior antiglycation efficacy of silymarin from Silybum marianum in human αA-crystallin: Implications for diabetic cataract prevention. Bioscience, Biotechnology, and Biochemistry. 2026. doi:10.1093/bbb/zbag005

BibTeX
@article{Yang2026,
  author = {Yang, Yen-Ju and Yu, Yi-Ping and Lin, Kuan-Hung and Lu, Chun-Ping},
  title = {Superior antiglycation efficacy of silymarin from Silybum marianum in human αA-crystallin: Implications for diabetic cataract prevention},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2026},
  doi = {10.1093/bbb/zbag005}
}
Kostenlos starten →